Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

Yuki Kinjo(Jikei University School of Medicine), Mitchell Kronenberg(La Jolla Institute for Immunology), Peter W. Andrew(University of Sheffield), Gurdyal S. Besra(University of Birmingham), Petr A. Illarionov(University of Birmingham), Hasan Yeşilkaya(University of Leicester), Samira Dahesh(University of California San Diego), Dirk M. Zajonc(La Jolla Institute for Immunology), Enrico Girardi(Austrian Academy of Sciences), Satoshi Uchiyama(University of California San Diego), Chi‐Huey Wong(Scripps Research Institute), Akiko Okawara(National Institute of Infectious Diseases), Archana Khurana(La Jolla Institute for Immunology), Paul Rogers(Fate Therapeutics (United States)), Victor Nizet(University of California San Diego), Moriya Tsuji(Aaron Diamond AIDS Research Center), Kazuyoshi Kawahara(Kanto Gakuin University), Masakazu Imamura(Kyushu University), Yali Li(State Key Laboratory of Biotherapy), Xiangming Li(The University of Texas MD Anderson Cancer Center), Yukihiro Kaneko(Osaka City University), Kazuyoshi Kawakami(Tohoku University), José Luis Vela(La Jolla Institute for Immunology), Anaximandro Gómez-Velasco(University of British Columbia), Bo Pei(La Jolla Institute for Immunology), Yoshitsugu Miyazaki(National Institute of Infectious Diseases)
Nature Immunology
September 4, 2011
Cited by 348


Related Papers